Is T3 appendiceal goblet cell adenocarcinoma still an oncological riddle for acute care surgeons? A case report

Submitted: May 30, 2023
Accepted: September 19, 2023
Published: October 3, 2023
Abstract Views: 243
PDF: 82
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Appendectomy for acute appendicitis is one of the most commonly performed surgical procedures nowadays. Here we present the case of a 48-year-old man who was admitted to our emergency department with abdominal pain suggestive of acute appendicitis. Then, the patient underwent a laparoscopic appendectomy, and the histological examination of the surgical specimen revealed an unexpected occult neoplasm: goblet cell adenocarcinoma (GCA). After a multidisciplinary evaluation, a right colectomy was performed with good oncological and clinical outcomes at the 1-year follow-up evaluation. To date, either nonoperative strategies or surgical radicalization treatment have been proposed for this condition. Therefore, the choice of the proper therapeutic algorithm is still a challenge for surgeons. This case report is an addition to the existing literature to hold surgeons' attention when managing such cases: multidisciplinary evaluation and patient-targeted therapies are the key steps to achieving good oncological and surgical outcomes.



PlumX Metrics


Download data is not yet available.


Cervellin G, Mora R, Ticinesi A, et al. Epidemiology and outcomes of acute abdominal pain in a large urban Emergency Department: retrospective analysis of 5,340 cases. Ann Transl Med 2016;4:362–362. DOI:
Tang LH, Shia J, Soslow RA, et al. Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol 2008;32:1429–43. DOI:
Taggart MW, Abraham SC, Overman MJ, et al. Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: Comparison of clinicopathologic features and prognosis. Arch Pathol Lab Med 2015;139:782–90. DOI:
McCusker ME, Coté TR, Clegg LX, Sobin LH. Primary malignant neoplasms of the appendix: A population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer 2002;94:3307–12. DOI:
Kowalsky SJ, Nassour I, AlMasri S, et al. Omission of right hemicolectomy may be safe for some appendiceal goblet cell adenocarcinomas: A survival analysis of the national cancer database. Ann Surg Oncol 2021;28:8916–25. DOI:
Andersson M, Andersson RE. The appendicitis inflammatory response score: a tool for the diagnosis of acute appendicitis that outperforms the Alvarado score. World J Surg. 2008;32:1843–9. DOI:
Di Saverio S, Podda M, De Simone B, et al. Diagnosis and treatment of acute appendicitis: 2020 update of the WSES Jerusalem guidelines. World J Emerg Surg 2020;15:27. DOI:
Gomes CA, Sartelli M, Di Saverio S, et al. Acute appendicitis: proposal of a new comprehensive grading system based on clinical, imaging and laparoscopic findings. World J Emerg Surg 2015;10:60. DOI:
Amin MB, Edge S, Greene F, et al. AJCC Cancer Staging Manual. Springer International Publishing; 2017. DOI:
Vons C, Barry C, Maitre S, et al. Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. Lancet 2011;377:1573–9. DOI:
Pape U-F, Perren A, Niederle B, et al. ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology 2012;95:135–56. DOI:
Fields AC, Lu P, Enzinger A, et al. Treatment patterns and outcomes in goblet cell carcinoid tumors of the appendix. J Surg Oncol 2019;120:1096–101. DOI:
Wang G, Li Q, Chen W. Chemotherapy in the treatment of different histological types of appendiceal cancers: a SEER based study. BMC Cancer 2021;21:778. DOI:
Palmer K, Weerasuriya S, Chandrakumaran K, et al. Goblet cell adenocarcinoma of the appendix: A systematic review and incidence and survival of 1,225 cases from an English cancer registry. Front Oncol 2022;12:915028. DOI:
Rossi RE, Luong T-V, Caplin ME, et al. Goblet Cell Appendiceal Tumors - Management Dilemmas and Long-Term Outcomes. Surg Oncol 2015;24:47–53. DOI:
Olsen IH, Holt N, Langer SW, et al. Goblet cell carcinoids: characteristics of a Danish cohort of 83 patients. PLoS One 2015;10:e0117627. DOI:
Tsang ES, McConnell YJ, Schaeffer DF, et al. Outcomes of surgical and chemotherapeutic treatments of goblet cell carcinoid tumors of the appendix. Ann Surg Oncol 2018;25:2391–9. DOI:
Madsen AH, Ladekarl M, Villadsen GE, et al. Effects of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of goblet cell carcinoma: A prospective cohort study. Ann Surg Oncol 2018;25:422–30. DOI:
Wajekar AS, Solanki SL, Patil VP. Postoperative complications and critical care management after cytoreduction surgery and hyperthermic intraperitoneal chemotherapy: A systematic review of the literature. World J Crit Care Med 2022;11:375–86. DOI:

How to Cite

Bergna, A., Salvetti, F., Carando, S., Monti, M., & Segalini, E. (2023). Is T3 appendiceal goblet cell adenocarcinoma still an oncological riddle for acute care surgeons? A case report. Case Reports in Emergency Surgery and Trauma, 1(1).